Nosis Bio, a startup developing new ways to deliver RNA therapies to specific cells, has struck partnerships with two pharma ...

Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that the company will present ...

Researchers have identified an ancient RNA-guided system that can target DNA, potentially expanding the genome-editing toolbox.

Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, ...

Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Sector ...

Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...

Porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs is economically devastating for the global ...

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...